CJC-1295 with DAC Research Overview
CJC-1295 with DAC is a synthetic growth hormone releasing hormone (GHRH) analogue peptide incorporating a drug affinity complex modification. This pharmaceutical-grade research compound represents an advanced peptide construct studied extensively in laboratory environments for its enhanced pharmacokinetic properties. Unlike its non-DAC counterpart, this variant demonstrates significantly extended circulating half-life characteristics in preclinical models, making it valuable for researchers investigating sustained growth hormone axis modulation. The DAC modification involves maleimidopropionic acid attachment, which facilitates albumin binding and prolongs bioavailability in research applications. Investigators at Stroid UK Shop can examine this compound’s unique binding properties and receptor selectivity profiles.
Laboratory Research Applications
Research scientists investigate CJC-1295 with DAC for its selective GHRH receptor binding characteristics and downstream signalling pathway activation. Studies examine how the DAC modification influences pharmacodynamic responses compared to endogenous GHRH peptides. Laboratory investigations focus on the compound’s ability to stimulate growth hormone release through specific receptor mechanisms while maintaining selectivity profiles. Researchers studying growth hormone axis biology utilise this peptide to examine pulsatile hormone secretion patterns and receptor desensitisation phenomena. The extended half-life properties allow for investigation of sustained receptor activation effects in controlled laboratory environments. Scientists exploring peptide-protein interactions can analyse the albumin binding characteristics that distinguish this variant from standard CJC-1295 peptide formulations. Comparative studies with other growth hormone secretagogues and research compounds from our peptides and SARMs categories provide comprehensive research frameworks.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | CJC-1295 DAC |
| Molecular Weight | Verify with supplier |
| CAS Number | Verify with supplier |
| Purity | Pharmaceutical grade |
| Form | Lyophilised powder |
| Storage Temperature | -20°C long-term |
| Reconstitution | Sterile water or saline |
| Stability | Extended vs non-DAC variant |
Research Compliance Statement
CJC-1295 with DAC 2mg pharmaceutical grade is supplied exclusively for in-vitro laboratory research applications by qualified researchers and institutions. This research compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with all applicable regulations governing peptide research in their jurisdiction. Proper laboratory protocols, safety equipment, and waste disposal procedures must be followed when handling this research material. Storage and reconstitution should follow established laboratory guidelines for peptide research compounds.
